Pharmacologic and genetic inhibition of cholesterol esterification reduces tumour burden: a pan-cancer systematic review and meta-analysis of preclinical models
A. Websdale, Y. Kiew, P. Chalmers, X. Chen, G. Cioccoloni, T. A. Hughes, X. Luo, R. Mwarazi, M. Poirot, H. Roberg-Larsen, R. Wu, M. Xu, M. A. Zulyniak, J. L. Thorne
This paper reviews preclinical studies showing that inhibiting cholesterol esterification reduces tumour burden across cancers, with SOAT inhibitors like avasimibe showing promise.
bioRxiv · Jun 12, 2021Cancer Biology